JCO: Need for Estradiol Assays With a Lower Functional Sensitivity in Clinical Studies Examining Postmenopausal Women Treated With Aromatase Inhibitors Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Friday, January 25, 2013

JCO: Need for Estradiol Assays With a Lower Functional Sensitivity in Clinical Studies Examining Postmenopausal Women Treated With Aromatase Inhibitors



1)  Need for Estradiol Assays With a Lower Functional Sensitivity in Clinical Studies Examining Postmenopausal Women Treated With Aromatase Inhibitors

2)  Author's Reply:
  "We are pleased that Pauwels et al1 have drawn readers' attention to the difficulties of measuring low baseline plasma levels of estrogen in postmenopausal women and the extra demands imposed by measurements in patients treated with aromatase inhibitors (AIs)...."

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.